Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Cyclo Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 13 | +1 |
| Shares | 263.7K | 331.0K | +67.3K (+25.5%) |
| Value | $2.70M | $2.23M | −$463.0K (−17.2%) |
New holders (2)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 12,200 | $82.0K | 0.00% |
| Renaissance Technologies LLC | 10,482 | $71.0K | 0.00% |
Sold out (1)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Advisory Services Network, LLC | 100 | $1.00K |